Lv626
2420 积分 2024-09-14 加入
Design and Optimization of LOXL2 and sGC Dual-Target Regulators Targeting Extracellular Matrix Dysregulation and Vasodilation for the Treatment of Pulmonary Arterial Hypertension
4天前
已完结
Decoding IL4I1: The Core role of metabolism-driven immune regulation and new perspectives on disease targeting
5天前
已关闭
A randomized, double-blind, placebo-controlled phase 1 trial of the topical pan–lysyl oxidase inhibitor PXS-6302 in mature scars
7天前
已完结
Novel PD-L1/VISTA Dual Inhibitor as Potential Immunotherapy Agents
7天前
已完结
VISTA inhibitors in cancer immunotherapy: a short perspective on recent progresses
7天前
已完结
Synthetic Strategy and Evaluation of the Benzyloxy Benzylamide Derivatives as Thymic Stromal Lymphopoietin Modulators for the Treatment of Atopic Dermatitis
8天前
已完结
Targeting QPCTL: An Emerging Therapeutic Opportunity
10天前
已完结
Discovery of Potent Allosteric DRP1 Inhibitors by Disrupting Protein–Protein Interaction with MiD49
12天前
已完结
Covalent Fragment Inhibits RhoA Activation by Guanine Exchange Factors
13天前
已完结
RHOAL57Vdrives the development of diffuse gastric cancer through IGF1R-PAK1-YAP1 signaling
14天前
已完结
皖公网安备34019202002308
